Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova, the director of the Czech State Institute for Drug Control (SUKL)

Irena Storova, the director of the (Czech) State Institute for Drug Control (SUKL) poses for photographer in Prague, Czech Republic, April 9, 2021. Storova is refusing to admit the Czech use of the Russian COVID vaccine Sputnik V unless it is approved by the European Medicines Agency (EMA). (CTK Photo/Vojtech Vlk)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)

E

Irena Storova

The Czech State Drugs Control Institute (SUKL) head Irena Storova gives an interview to Czech News Agency (CTK) in Prague, Czech Republic, February 12, 2021. The SUKL will send details on the first Czech case of suspected death over the vaccine against COVID-19 to the European database of suspected adverse drug reaction reports, SUKL spokeswoman told CTK yesterday. Since the launch of the vaccination, SUKL has received 531 reports on suspected undesirable effects of the vaccine, such as nausea and flu-like symptoms. SUKL head Irena Storova said this corresponds to what had been expected based on the previous clinical studies. (CTK Photo/Roman Vondrous)